Current Issue

Advanced Therapy Medicinal Products Technology Transfer Challenges – Part 3

Robert Dream, Managing Director, HDR Company LLC

Advances and Challenges in Vaccine Development and Manufacture

Tony D’Amore, Ph.D. MBA, Board Member, Scientific Advisor and Independent Consultant for...

Endotoxin Control Strategies for Parenteral Drug Product Manufacturing

Robert Simler, Associate Vice President, Process Development, Amgen (previously Associate ...

Current Trends in Control and Monitoring of Subvisible Particulate Matter in Biotherapeuti...

Satish (Kumar) Singh, Vice President, Drug Product Development, Astria Therapeutics, Inc. ...

Lifetime Study for JSR Amsphere A3 – Protein A Resin

JSR Life Sciences



Careers

Delivering Better Outcomes for Patients Starts with Creating a Workplace Where all Colleagues Can Thrive

Ahmed Elhusseiny, Roche Pharmaceuticals, Area Head, Asia Pacific

Amgen is a Company that Cares about People, I Feel Genuinely Listened to Here

Jason Rudd, Amgen, Statistical Programming Manager

Inspiring the Next Generation at Bristol Myers Squibb

Elizabeth Jurica, Bristol Myers Squibb, Principal Scientist

A Great Working Atmosphere, Strong Collegial Relationships, and Opportunities to Grow at Lonza

Vijetha Bhat, Lonza, Houston,Texas, Scientist, Research and Development

At Bayer We Foster an Environment of Openness and Understanding Not Pity

Jürgen Schrapp, Bayer, Head of R&D Procurement

The Best Thing About Evotec, Without Question, Is The People

Stuart Flanagan, Evotec, Group Leader

View All Careers Articles

Headline News

Lilly outlines how eligible Medicare Part D patients can access its GLP-1 weight management medicines


Sanofi’s Cenrifki receives approval as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses


Lilly launches “The Memory Radio Station” across Europe, inviting the public to visually reconstruct fading memories through generative AI


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

New Tools to Assess the Risk of Microbial Impurities in the Pharmaceutical Manufacturing Process

Presented by Dr Friedrich von Wintzingerode, Senior Manager, Global Analytical Science & Technology (gASAT) Microbiology, Global QC bei Roche and Mathilde Arnault, Research Scientist, BioMonitoring R&D, Merck KGaA, Darmstadt, Germany
09th April 2019


Implementing a Quality by Design (QBD) Approach In Integrated DSP In-Line PAT Advanced Analytical Technologies to Monitor Critical Quality Attributes.

Presented by Dejan Arzenšek, Principal Scientist at Novartis and Justin Moretto, Life Science Product Marketing Manager at Kaiser Optical Systems, Inc
06th September 2021


Making Virus Inactivation a Reality for Continuous Upscaled Processes

Presented by Mark Schofield, Ph.D., Principal R&D Engineer, Pall Life Sciences - Westborough, MA, USA
30th November 2017


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia